Form4insider filings, from the source

Company · CIK 0001424812 · SIC 2834 — Pharmaceutical Preparations

Amarantus Bioscience Holdings, Inc. · AMBS

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $31k · 3sales $0 · 0net $31k
$10k$10k$100k$100k$1M$1MbuyssalesApr 7May 17Jun 26Aug 5Sep 14Oct 24Dec 3

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Feb 1, 2016 JForm 4 →Feb 2, 10:35 am ESTGerald CommissiongCEO, Director45,283$0.265$12,000100,347— plan?
Dec 2, 2015 PForm 4 →Dec 4, 8:54 am ESTRobert Lewis HarrisDirector19,500$0.478$9,32196,070+25.5% plan?
Apr 9, 2015 PForm 4 →Apr 9, 3:29 pm EDTRobert Edward FarrellCFO200,000$0.0499$9,980333,333+150% plan?
Apr 8, 2015 PForm 4 →Apr 8, 2:00 pm EDTGerald CommissiongCEO, Director240,000$0.048$11,5168,259,565+2.99% plan?

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jan 12, 2015 AForm 4 →Jan 15, 6:00 am ESTJoseph RubinfeldDirector6,690,000——6,690,000— late
Jan 12, 2015 AForm 4 →Jan 14, 5:24 pm ESTRoss Iain GladstoneDirector6,490,000——6,490,000—
Jan 12, 2015 AForm 4 →Jan 14, 5:22 pm ESTDonald D HuffmanDirector6,490,000——6,490,000—
Jan 12, 2015 AForm 4 →Jan 14, 5:18 pm ESTRobert Lewis HarrisDirector600,000——600,000—